Clinical Trial Update: Adjuvant TACE to Reduce the HCC Recurrence After Resection [Phase 3]

View source ↗

Summary

This document reports an update on a Phase 3 trial evaluating adjuvant transarterial chemoembolization (TACE) to reduce recurrence of hepatocellular carcinoma a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Carcinoma, Hepatocellular | Phase 3 | Status: COMPLETED